Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 28 Nov 2022 for Arcturus Therapeutics Holdings Inc., €80k. Read the official filing
Filing timeline
BuySaleJoseph E. Payne
Insider track record
Disclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Joseph E. Payne: trading record in brief
Joseph E. Payne is a declared insider at 2 companies (board member); the most frequent names are Arcturus Therapeutics Holdings Inc. and GRI BIO, Inc. We count 2 filings; the first trade dates from 25 May 2021 and the latest from 23 November 2022.
Every open-market trade on record is a purchase: 2 purchases worth €114k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2022: 1 purchase and no sales on the market.
Most recently, on 28 November 2022, the filings show an open-market purchase worth €80k in Arcturus Therapeutics Holdings Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Joseph E. Payne
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
5,000 shares@ US$16.51100.0% of flowCommon StockSEC:0001193805-22-001614:0
Canonical exit: 21 Feb 2023 (T+90)
10,700 shares@ US$3.85100.0% of flowCommon StockSEC:0001104659-21-073495:0
Canonical exit: 23 Aug 2021 (T+90)
2 of 2 declarations
